spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  FulFil 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 26 May 2026
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer
Devices Urology Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2026
Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio
Devices Distribution
 HSMN NewsFeed - 27 Mar 2026
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Dec 2025
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2025
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE(R) VIABIL(R) Biliary Endoprosthesis in the United States
Devices Distribution
 HSMN NewsFeed - 24 Nov 2025
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
Devices Urology Regulatory
 HSMN NewsFeed - 24 Oct 2025
Terumo Interventional Systems Announces Its New OPUSWAVE(R) Dual Sensor Imaging System and DualView(R) Imaging Catheter Receive FDA 510(k) Clearance
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 6 Oct 2025
Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio
Devices Interventional Distribution
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 12 Jun 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2025
Hemispherian Receives Positive Opinion for Orphan Medicinal Product Designation in the EU for GLIX1 in Glioma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jan 2025
FDA Approves LUMAKRAS(R) (Sotorasib) in Combination with Vectibix(R) (Panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Jan 2025
RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2024
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2024
Alltrna Announces Updates to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2024
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 May 2024
Rad AI Closes $50 Million to Empower Physicians with AI
Devices Radiology Venture Capital
 HSMN NewsFeed - 2 May 2024
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 26 Dec 2023
Amgen Provides Regulatory Update on Status of Lumakras(R) (Sotorasib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2023
EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
Diagnostics Regulatory
 HSMN NewsFeed - 10 Jul 2023
PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovation
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 29 Jun 2023
Shane Brown Promoted to President of GT Medical Technologies, Inc.
Devices Oncology Personnel
 HSMN NewsFeed - 3 Apr 2023
Laborie Launches alpHaONE, an Innovative GERD Diagnostic System
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 3 Mar 2023
Aadi Bioscience Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2022
Geistlich Pharma North America, Inc. Acquires Lynch Biologics, LLC, a Biologics and Tissue Engineering Company
Regenerative Medicine Surgery Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2022
Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Sep 2022
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Devices Surgery Product Launch
 HSMN NewsFeed - 12 Sep 2022
Phantom Neuro Raises $6M in Expanded Seed Funding for Company Growth and Development of Advanced Platform for Patient Capability Restoration
Devices Neurology Orthopaedic Venture Capital
 HSMN NewsFeed - 7 Sep 2022
STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jul 2022
Checkpoint Surgical launches Checkpoint Edge(TM) Nerve Cutting Kit, extending the company's intraoperative nerve care portfolio
Devices Surgery Product Launch
 HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Jul 2022
Molecular Testing Labs Announces Selection of Eric Strafel as New CEO
Diagnostics Personnel
 HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices
 HSMN NewsFeed - 12 Jul 2022
Accuray CyberKnife(R) System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications
Devices Oncology Neurosurgery
 HSMN NewsFeed - 25 May 2022
Tryp Therapeutics Strengthens Board of Directors with Appointment of Chris Ntoumenopoulos as Independent Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2022
NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2022
MedTech Company STENTiT Raises €1.8 million in Seed Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 31 Mar 2022
Alberto Mas Announces Intent to Retire from BD at End of Fiscal Year
Devices Personnel
 HSMN NewsFeed - 28 Mar 2022
Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2022
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch
 HSMN NewsFeed - 31 Jan 2022
Spatz3 Adjustable Balloon Delivers the Highest Weight Loss Results
Devices Gastroenterology
 HSMN NewsFeed - 24 Nov 2021
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2021
BioMarin Receives FDA Approval for VOXZOGO(TM) (vosoritide) for Injection, Indicated to Increase Linear Growth in Children with Achondroplasia Aged 5 and Up with Open Growth Plates
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2021
Trendlines Announces Acquisition of Portfolio Company OrthoSpin Ltd.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2021
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
Devices Orthopaedic Dental Venture Capital
 HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Diagnostics Personnel
 HSMN NewsFeed - 13 Sep 2021
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
Diagnostics Personnel
 HSMN NewsFeed - 31 Aug 2021
Bactiguard recruits Chief Licensing Officer to accelerate growth
Devices Licensing Personnel
 HSMN NewsFeed - 13 Aug 2021
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 5 Aug 2021
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led By Sorrento Therapeutics And Including Existing Investors And The Foundation For Prader-Willi Research
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jun 2021
Dutch MedTech STENTiT appoints Golo von Basum as Chief Operating Officer
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Jun 2021
STARBOARD MEDICAL, INC. strengthens its intellectual property with issuance of new patent covering Clik-FIX Catheter Securement through 2038
Devices
 HSMN NewsFeed - 14 Jun 2021
Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions
 HSMN NewsFeed - 26 Apr 2021
Phoenix Cardiac Receives CE Mark for its Innovative BACE Device to Treat Functional Mitral Regurgitation
Devices Cardiology Regulatory
 HSMN NewsFeed - 12 Apr 2021
Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
Devices Gastroenterology FDA
 HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
Devices Ophthalmology FDA
 HSMN NewsFeed - 22 Mar 2021
Oakrum Pharma and Aucta Pharma Announce U.S. FDA Approval of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Diagnostics FDA
 HSMN NewsFeed - 8 Mar 2021
BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 Dec 2020
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for its Lead Product, ASP-1929 in Combination with Anti-PD1 Therapy, for Head and Neck Cancer or Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Dec 2020
Leading BioSciences and Seneca Biopharma Announce Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2020
Echolight Announces New Executive Hires
Devices Personnel
 HSMN NewsFeed - 24 Nov 2020
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
Devices Cardiology Monitoring Venture Capital
 HSMN NewsFeed - 19 Nov 2020
SynOx Therapeutics raises €37M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Nov 2020
Avion Pharmaceuticals, LLC, to Expand Its Women's Healthcare Portfolio of Products
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 22 Oct 2020
Michigan State University and Leica Microsystems Establish Center of Excellence in Microscopy
Devices
 HSMN NewsFeed - 6 Oct 2020
Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2020
BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Receives FDA Fast Track Designation for PKU Investigational Gene Therapy, BMN 307
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Sep 2020
MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2020
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Aug 2020
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
Devices Urology Oncology Venture Capital
 HSMN NewsFeed - 19 Aug 2020
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera(R)
Biopharmaceuticals Generics Neurology Product Launch
 HSMN NewsFeed - 15 Jul 2020
Paragon 28, Inc. is pleased to announce that the U.S. Food and Drug Administration has cleared the APEX 3D(TM) Total Ankle Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 7 Jul 2020
Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Diagnostics Oncology
 HSMN NewsFeed - 16 Jun 2020
Keystone Heart, A Venus Medtech Company, Acquires 510 Kardiac Devices, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2020
Olympus Announces Market Availability of the New TJF-Q190V Duodenoscope
Devices Product Launch
 HSMN NewsFeed - 18 May 2020
Akcea Announces Appointment of New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Diagnostics Oncology Personnel
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Mar 2020
CytoSorb(R) Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care
Devices Regulatory
 HSMN NewsFeed - 31 Mar 2020
OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 31 Mar 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 24 Mar 2020
Updates from Lilly about Insulin Supply and Affordability
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 25 Feb 2020
KAHR Medical Raises $18 Million in Private Funding Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Feb 2020
Duke University and Leica Microsystems Establish Center of Excellence in Microscopy
Devices
 HSMN NewsFeed - 11 Feb 2020
Caris Life Sciences Appoints New Executive Medical Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 31 Jan 2020
Olympus Announces FDA Clearance of the TJF-Q190V Duodenoscope
Devices Gastroenterology FDA
 HSMN NewsFeed - 9 Jan 2020
enGene Announces Additions to Senior Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Jan 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint(R) Testing through Techniker Krankenkasse
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Nov 2019
Olympus Unveils Corporate Strategy
Devices
 HSMN NewsFeed - 5 Nov 2019
Olympus Now the Exclusive Distributor of the RocaFlow Pump and Tubing Sets
Devices Urology Distribution
 HSMN NewsFeed - 17 Oct 2019
Exclusive Distribution Agreement Adds eSuction Distal Cap to Olympus EndoTherapy Portfolio
Devices Gastroenterology Distribution
 HSMN NewsFeed - 14 Oct 2019
OssDsign Receives US FDA Clearance for Cranial PSI Accessories - Strengthening Business Position in the US
Devices Neurosurgery FDA
 HSMN NewsFeed - 26 Sep 2019
BD Announces Leadership Succession Plan
Devices Diagnostics Personnel
 HSMN NewsFeed - 25 Sep 2019
Body Vision Closing $20 Million in Series C Funding
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 12 Sep 2019
Olympus Launches New Generation Video Rhino-Laryngoscopes
Devices Product Launch
 HSMN NewsFeed - 5 Sep 2019
Arthrosurface Receives FDA Clearance for BOSS(TM) Toe Fixation System
Devices Orthopaedic FDA
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2019
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 13 Jun 2019
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue(R) Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
Devices Interventional Licensing
 HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2019
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)
Diagnostics Oncology
 HSMN NewsFeed - 3 May 2019
Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Transcriptome(TM) Companion Diagnostic Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 1 May 2019
Caris Life Sciences Acquires Pharmatech
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Mar 2019
Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2019
Fujifilm Launches Three New Software Tools For Its ASPIRE Cristalle Digital Mammography System
Devices Radiology Oncology Product Launch
 HSMN NewsFeed - 1 Mar 2019
Rakuten Aspyrian Announces Name Change to Rakuten Medical
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Feb 2019
FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Feb 2019
Viriom Announces New CEO Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2019
NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System
Devices Orthopaedic FDA Regulatory
 HSMN NewsFeed - 12 Feb 2019
Clinical Trial Reports That Re-Treatment With A Single TearCare(R) Treatment Continues To Provide Relief For Patients With Dry Eye Disease
Devices Ophthalmology
 HSMN NewsFeed - 11 Jan 2019
Olympus Corporation Promotes U.S.-Based Company Leaders to Global Roles
Devices Personnel
 HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Dec 2018
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Devices FDA
 HSMN NewsFeed - 3 Dec 2018
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 31 Oct 2018
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
Diagnostics Venture Capital
 HSMN NewsFeed - 4 Oct 2018
Olympus Introduces OER-Mini Endoscope Reprocessor for ENT
Devices Product Launch
 HSMN NewsFeed - 1 Oct 2018
Body Vision Medical Announces the Release of LungVision(TM)
Devices Diagnostics Product Launch
 HSMN NewsFeed - 13 Sep 2018
Olympus Introduces EZ Shot 3 Plus 25 G EUS Needle with Enhanced Maneuverability for Uncompromised Access to Any Lesion, Consistent Performance to Potentially Reduce Procedural Costs and Procedure Time
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology
 HSMN NewsFeed - 22 Aug 2018
Olympus and FlexDex Announce Exclusive Distribution Agreement
Devices Surgery Distribution
 HSMN NewsFeed - 3 Aug 2018
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
Devices Interventional Acquisitions Reimbursement
 HSMN NewsFeed - 23 Jul 2018
OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 19 Jul 2018
Olympus Appoints New Director of Medical and Surgical Business for the UK and Ireland
Devices Personnel
 HSMN NewsFeed - 13 Jul 2018
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2018
Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of PIXUVRI(R) (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jul 2018
Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Biopharmaceuticals Oncology Drug Delivery Acquisitions
 HSMN NewsFeed - 29 Jun 2018
I-Mab Successfully Raised USD 220 Million in Series C Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Jun 2018
Caris Life Sciences Expands Management Team
Diagnostics Personnel
 HSMN NewsFeed - 21 Jun 2018
Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Diagnostics Oncology
 HSMN NewsFeed - 14 Jun 2018
Venus Medtech Enters North American Market
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 17 May 2018
Award-Winning Olympus Brings a "Full Circle" Urology Offering to AUA
Devices Urology Product Launch
 HSMN NewsFeed - 17 May 2018
Olympus Expands Its Endoscope Reprocessing Portfolio to Include ChanlDry Drying Cabinet, Endo SafeStack Transport Cart and Visual Reprocessing Guide
Devices Product Launch
 HSMN NewsFeed - 27 Apr 2018
BD Names Three Executives to Segment Leadership Roles
Devices Personnel
 HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 20 Mar 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Feb 2018
Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Feb 2018
7D Surgical Completes Significant Round of Financing
Devices Surgery Venture Capital
 HSMN NewsFeed - 17 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the 'intended use' of medical products
Devices FDA
 HSMN NewsFeed - 12 Jan 2018
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
Devices FDA
 HSMN NewsFeed - 8 Jan 2018
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2018
Taiho Oncology Names Timothy Whitten President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Dec 2017
PENTAX Medical Appoints Veteran Executive As The Americas Region President And CEO
Devices Gastroenterology Personnel
 HSMN NewsFeed - 14 Dec 2017
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 14 Dec 2017
Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus(R) Patents
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 30 Nov 2017
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Nov 2017
U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 16 Nov 2017
Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA advisory about deadly risks associated with Kratom
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2017
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Sep 2017
Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 31 Aug 2017
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2017
Merrimack Augments Executive Team with Appointment of Jean Franchi as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2017
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 27 Jul 2017
Valeant Announces U.S. Launch of SILIQ(TM) (brodalumab) Injection
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 24 Jul 2017
Elekta Introduces Advanced Cancer Treatment to Kingdom of Bhutan
Devices Oncology
 HSMN NewsFeed - 11 Jul 2017
Prometic Announces Positive Long Term Clinical Data on Ryplazym(TM) in Plasminogen Congenital Deficiency and Provides Regulatory Update
Biopharmaceuticals
 HSMN NewsFeed - 22 Jun 2017
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2017
Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jun 2017
Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 1 Jun 2017
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
Diagnostics FDA
 HSMN NewsFeed - 17 May 2017
Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 28 Apr 2017
Invivoscribe(R) Receives FDA Approval for the LeukoStrat(R) CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt(R) and is the First Companion Diagnostic for AML
Diagnostics Personalized Medicine Oncology FDA
 HSMN NewsFeed - 28 Apr 2017
Olympus Announces Intention to Acquire Image Stream Medical, Inc. to Enhance Medical Solution Offerings to Healthcare Facilities
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Apr 2017
Merrimack Appoints Daryl Drummond, Ph.D. as Head of Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed(R) Products
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 16 Mar 2017
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 16 Mar 2017
Shire Receives European Approval for Label Extension of CINRYZE(R) (C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 28 Feb 2017
Muse bio secures $23M Series B financing led by Venrock
Devices Venture Capital
 HSMN NewsFeed - 23 Feb 2017
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
Devices FDA
 HSMN NewsFeed - 16 Feb 2017
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 30 Jan 2017
ZDi Solutions, LLC Announces Justin Sims as Executive Vice President of Sales
Devices Oncology Personnel
 HSMN NewsFeed - 27 Jan 2017
Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jan 2017
ZELTIQ Aesthetics, Inc. Announces Commercial Leadership Transition
Devices Dermatology Personnel
 HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2016
Genomic Health Announces Results from Multiple Oncotype DX(R) Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 7 Dec 2016
Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for TroClose1200(TM)
Devices Surgery FDA Venture Capital
 HSMN NewsFeed - 28 Nov 2016
B. Braun / Trendlines Partnership Leads to ApiFix Investment
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 25 Nov 2016
DEPArray(TM) Single-Cell Isolation Technology Enables Researchers to Develop a Model for Predicting Response to Treatment in Patients with Lung Cancer
Diagnostics Oncology
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Oct 2016
GenesisCare Continues to Expand Spanish Cancer Services with Elekta
Devices Oncology
 HSMN NewsFeed - 26 Aug 2016
Alere Issues Statement
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 23 Aug 2016
ImPACT(R) is the First Concussion-Specific Medical Device to Receive FDA Clearance
Devices Neurology FDA
 HSMN NewsFeed - 2 Aug 2016
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2016
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Jul 2016
Vensica Medical Completes $500,000 Finance Round
Devices Drug Delivery Urology Venture Capital
 HSMN NewsFeed - 11 Jul 2016
David Meek appointed as Chief Executive Officer of Ipsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2016
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 May 2016
Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 3 May 2016
Intec Pharma Appoints VP of Clinical and Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Apr 2016
John Lapré to Fulfill Role as Elekta’s Chief Technology Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 8 Apr 2016
Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 1 Apr 2016
Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Mar 2016
GenesisCare and Elekta Sign Strategic Partnership for More Than USD 100 Million
Devices Oncology
 HSMN NewsFeed - 29 Feb 2016
CHMP Issues Positive Opinion for LONSURF(R) (trifluridine/tipiracil) for Refractory Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Feb 2016
Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch
 HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Feb 2016
BioPharmX Appoints Marie-Louise Bots as Senior VP of Corporate Development
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Jan 2016
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
Devices Diagnostics Litigation
 HSMN NewsFeed - 5 Jan 2016
Glenn P. Sblendorio to Join Ophthotech as Executive Vice President, Chief Operating Officer and Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 10 Dec 2015
CareFusion Receives Two 510(k) Clearances For Spine Products
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 2 Dec 2015
Cesca Receives Approval for Medicare Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Nov 2015
AliveCor Announces Appointment of Chief Executive Officer
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 26 Oct 2015
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
Devices Distribution
 HSMN NewsFeed - 18 Sep 2015
Infinity Expands Pipeline with Addition of IPI-549, an Immuno-Oncology Development Candidate for the Treatment of Solid Tumors
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Aug 2015
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Devices Neurology Product Launch
 HSMN NewsFeed - 29 Jul 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology
Devices Interventional
 HSMN NewsFeed - 23 Jul 2015
St. Jude Medical and Thoratec Announce Definitive Agreement
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2015
Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2015
Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel(TM) XR
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 24 Apr 2015
Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 Apr 2015
Sagent Pharmaceuticals Appoints Michael Logerfo as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2015
Caris Life Sciences Appoints Dr. David Spetzler Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2015
Sagent Pharmaceuticals Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Feb 2015
REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Feb 2015
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Devices Interventional FDA
 HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Devices Interventional Acquisitions
 HSMN NewsFeed - 2 Dec 2014
Xeltis Closes EURO 27 Million / USD 34 Million Series B Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 5 Nov 2014
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Oct 2014
Regado Biosciences Appoints Michael A. Metzger CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2014
Aymeric Le Chatelier joins Ipsen as Executive Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2014
OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2014
Imprimis Pharmaceuticals Appoints Healthcare Leader William H. Nelson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2014
Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2014
Toshiba is First MR Manufacturer to Meet Network Security Guidelines of the U.S. Department of Defense
Devices Radiology
 HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
Devices Drug Delivery Endocrinology Product Launch
 HSMN NewsFeed - 5 Aug 2014
Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling
Diagnostics Oncology
 HSMN NewsFeed - 5 Aug 2014
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
Diagnostics Personnel
 HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
Diagnostics FDA
 HSMN NewsFeed - 22 Jul 2014
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 9 Jul 2014
CIMTEC announces spin-off company Focal Healthcare, Inc. to develop the new "gold standard" of targeted prostate biopsy and therapy devices for the management of prostate cancer
Devices Oncology Urology
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2014
Ipsen submits marketing authorization applications in the US and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jun 2014
SoluMatrix(R) Meloxicam Demonstrates Significant Efficacy at 30 Percent Lower Doses in the Treatment of Osteoarthritis
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2014
Dehaier Receives CFDA Approval for Morpheus Ox Sleep Diagnostic Software
Devices Regulatory
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 May 2014
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 May 2014
The BD MAX(TM) Enteric Bacterial Panel Receives FDA Clearance to Detect the Most Common Causes of Bacterial Gastroenteritis
Diagnostics FDA
 HSMN NewsFeed - 5 May 2014
FDA Approves Conversion of Soliris(R) (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2014
Norgenix And CrossBay Medical Announce Strategic Alliance and Medical Device Promotion
Devices Distribution
 HSMN NewsFeed - 22 Apr 2014
Lilly Announces Agreement to Acquire Novartis Animal Health
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 Apr 2014
23andMe Appoints Dr. Jill Hagenkord Chief Medical Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 16 Apr 2014
Provista Diagnostics Secures $6MM Series B Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 14 Apr 2014
Mevion Medical Systems Announces An Exclusive Partnership with Chiyoda Technol Corporation for Distribution of the MEVION S250 Proton Therapy System in Japan
Devices Oncology Distribution
 HSMN NewsFeed - 24 Mar 2014
Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Mar 2014
Mike Sullivan named President of Avion Pharmaceuticals, LLC
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Mar 2014
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Diagnostics Oncology
 HSMN NewsFeed - 7 Feb 2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
Devices Personnel
 HSMN NewsFeed - 7 Feb 2014
Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Feb 2014
Ipsen announces clinical results of Dysport(R) Next Generation (DNG) and its intent to file the first ready-to-use liquid toxin A in Europe and ROW(1)
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2014
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 10 Jan 2014
Jonathan Barnsley Joins Ipsen as Executive Vice President, Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
BD Acquires Alverix, Inc.
Devices Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2013
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2013
CorMedix Announces First Sales of Neutrolin(R) in the European Union
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 6 Dec 2013
Cardinal Health Launches New Service To Help Hospitals Expand Reach Of Their Outpatient Pharmacies
Biopharmaceuticals Distribution Product Launch
 HSMN NewsFeed - 5 Dec 2013
23andMe, Inc. Provides Update on FDA Regulatory Review
Diagnostics FDA
 HSMN NewsFeed - 29 Nov 2013
New Data Show Efficacy, Safety and Tolerability of Xeplion(R) in Patients with Schizophrenia at Various Stages of the Disease
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2013
Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable Alternative to Surgery for Early-Stage Lung Cancer Patients
Devices Oncology
 HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 7 Nov 2013
Salix Pharmaceuticals to Acquire Santarus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2013
GORE(R) EXCLUDER(R) Iliac Branch Endoprosthesis Is First Dedicated System of Its Kind Approved in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2013
Nuron Biotech Announces Appointment of New Management Team Members and Provides an Update on Commercial Vaccine Meningitec(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Oct 2013
VeriTeQ Partner Establishment Labs Receives CE Mark Approval to Market Motiva Implant Matrix Ergonomix Breast Implant with VeriTeQ’s Q Inside Safety Technology
Devices Regulatory
 HSMN NewsFeed - 9 Oct 2013
Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to India
Devices
 HSMN NewsFeed - 20 Sep 2013
Biomed Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2013
New York Proton Consortium Expands Access to Proton Therapy Through Agreement with ProCure Proton Therapy Center in New Jersey
Devices Oncology
 HSMN NewsFeed - 1 Aug 2013
Artimplant applies for its own bankruptcy
Devices Orthopaedic
 HSMN NewsFeed - 26 Jul 2013
Gentium Receives Positive Opinion From EMA's CHMP for Defitelio
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jun 2013
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
Diagnostics FDA
 HSMN NewsFeed - 27 Jun 2013
AngioDynamics Announces FDA Clearance for Xcela Plus Port Family With PASV Technology
Devices FDA
 HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 14 Jun 2013
Lumenis Launches New Fractional Non-Ablative Laser Module, the ResurFX(TM), at the 22nd Annual Meeting of the German Dermatologic Laser Society in Potsdam
Devices Dermatology Product Launch
 HSMN NewsFeed - 14 Jun 2013
Ipsen Reorganizes Its US Neurology Platform and Confirms Its Goal to Become Profitable in the US in 2014
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jun 2013
Mindray Announces Appointment of Three Members to Its Executive Team
Devices Personnel
 HSMN NewsFeed - 29 May 2013
Hansen Medical Announces U.S. Food and Drug Administration Conditionally Approves New Study Design Evaluating the Use of the Artisan(R) Family of Control Catheters With the Sensei(R) X Robotic System for the Treatment of Atrial Fibrillation
Devices Cardiology FDA
 HSMN NewsFeed - 7 May 2013
OrbusNeich enforces injunction against Boston Scientific in Germany
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Apr 2013
Lumenis Introduces New FiberLase(TM) Drop-In Guide to Extend the Capabilities of Gynecologists and ENT Surgeons in Robotic Surgery
Devices Product Launch
 HSMN NewsFeed - 9 Apr 2013
Arrhythmia Research Technology, Inc. Announces New President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 14 Mar 2013
Denmark's Odense University Hospital Orders Elekta's New Versa HD Linear Accelerator for Radiotherapy Treatment of Patients with Cancer
Devices Oncology
 HSMN NewsFeed - 14 Mar 2013
EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer
Devices Oncology Product Launch
 HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 27 Feb 2013
Elekta Focuses on Clinical Workflows with MOSAIQ Oncology Information Management System at HIMSS13 Meeting
Devices Oncology
 HSMN NewsFeed - 27 Feb 2013
Christel Bories Joins Ipsen as Deputy Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2013
Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
Devices Distribution Mergers & Acquisitions
 HSMN NewsFeed - 4 Feb 2013
CyVek, Inc. Secures $5.5 Million in Series D Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2013
Kevin Sayer Appointed as Chief Operating Officer of DexCom
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 6 Jan 2013
AWAK Technologies Enters into an Exclusive Agreement with Baxter International for the Development of Wearable Dialysis Technology
Devices
 HSMN NewsFeed - 20 Dec 2012
Venaxis Board Appoints Senior Diagnostics Executive to Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 26 Nov 2012
Toshiba’s New MR Series Offers Technology Investment for the Future
Devices Radiology
 HSMN NewsFeed - 20 Nov 2012
Ipsen and Inspiration Biopharmaceuticals Announce That OBI-1 Has Received Fast Track Designation from FDA for Acquired Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2012
Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Oct 2012
Sagent Pharmaceuticals Announces the Launch of Leucovorin Calcium for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Oct 2012
Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
Devices Radiology Oncology
 HSMN NewsFeed - 22 Oct 2012
DARA BioSciences Launches Soltamox(R), First and Only Liquid Version of Tamoxifen Citrate
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2012
Accuray Incorporated CEO Resigns, Board Appoints Successor for Next Phase of Growth
Devices Oncology Personnel
 HSMN NewsFeed - 8 Oct 2012
Spectranetics Announces U.S. Launch of the TAPAS(TM) Catheter and Preclinical Animal Data on Drug Uptake in Peripheral Vessels
Devices Interventional Drug Delivery Distribution
 HSMN NewsFeed - 8 Oct 2012
U.S. FDA Approves the Dexcom G4(TM) PLATINUM Continuous Glucose Monitor (CGM)
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 4 Oct 2012
Boston Therapeutics Wins FDA Approval to File an Abbreviated New Drug Application for PAZAMET(TM) to Treat Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Diagnostics Oncology
 HSMN NewsFeed - 18 Sep 2012
DFINE Announces Full U.S. Commercial Release of STAR Tumor Ablation System
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 22 Aug 2012
Edge Therapeutics Appoints Drug-Delivery Luminary Dr. Robert Langer to Chair Scientific Advisory Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2012
Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jun 2012
Aptus Endosystems Completes $25 Million Series BB Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 26 Jun 2012
Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
Diagnostics Oncology
 HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jun 2012
Biomet Announces Initial Closing of DePuy Trauma Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Peripheral Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2012
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 10 May 2012
Cardionovum(R) Will Launch Two Drug-Eluting Balloon (DEB) Dilatation Catheter Product Families at EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2012
New HydraSolve(TM) Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
Devices Surgery
 HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Devices Acquisitions
 HSMN NewsFeed - 1 May 2012
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 18 Apr 2012
Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 10 Apr 2012
Medtronic Receives FDA Approval to Treat Mildly Symptomatic Heart Failure Patients Through Expanded Indication for CRT-D
Devices Cardiology FDA
 HSMN NewsFeed - 7 Apr 2012
SciClone Announces Board of Directors and Officer Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2012
Biomet Announces Offer to Acquire DePuy Trauma Business
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 2 Apr 2012
Varian Medical Systems Establishes Office in Hungary to Support Local Radiotherapy Departments
Devices Oncology
 HSMN NewsFeed - 14 Mar 2012
Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data
Devices Cardiology FDA
 HSMN NewsFeed - 12 Mar 2012
Asahi Kasei Announces Agreement to Acquire ZOLL Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2012
Mazor Robotics Signs Agreement with Distributor for China
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 2 Feb 2012
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 24 Jan 2012
Spectranetics Strengthens Peripheral Vascular Portfolio with a Partnership to Distribute the TAPAS™ Catheter
Devices Distribution
 HSMN NewsFeed - 20 Jan 2012
Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Jan 2012
Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen(TM) in South Korea
Devices Wound Care Distribution
 HSMN NewsFeed - 1 Jan 2012
Teva Announces Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Nov 2011
Dendreon Announces the Centers for Medicare and Medicaid Services (CMS) Will Now Cover Infusion Costs Associated with the Administration of PROVENGE
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 17 Nov 2011
Agios Secures $78 Million in Oversubscribed Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 7 Nov 2011
Abbott Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2011
Leading Swedish University Hospital Orders Four TrueBeam Radiotherapy Systems from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Oct 2011
Elekta Divests Its Anatomic Pathology Information System
Devices
 HSMN NewsFeed - 2 Oct 2011
Nucletron, an Elekta Company, Receives FDA 510(k) Clearance for Precise Vaginal CT/MR Multi Channel Applicator
Devices Oncology FDA
 HSMN NewsFeed - 13 Sep 2011
Advanced Bionics Announces FDA Approval for U.S. Market Re-Entry of the HiRes 90K Cochlear Implant
Devices FDA
 HSMN NewsFeed - 25 Aug 2011
Baxter to Acquire Privately Held Baxa Corporation
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2011
German Patient Surpasses 5 Years of Support on DuraHeart Left Ventricular Assist Device
Devices Cardiology
 HSMN NewsFeed - 12 Jul 2011
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 7 Jul 2011
Medtronic To Acquire PEAK Surgical, Inc.
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jun 2011
Cayenne Medical, Inc. Appoints Dev K. Mishra, M.D., Medical Director
Devices Orthopaedic Personnel
 HSMN NewsFeed - 31 May 2011
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
Devices Interventional
 HSMN NewsFeed - 20 May 2011
European Medicines Agency’s Committee for Medicinal Products for Human Use Issues Positive Opinion on Marketing Authorisation Application for FAMPYRA
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 16 May 2011
Lilly Provides Its Perspective in Response to Amylin Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 May 2011
Lilly Provides Statement in Response to Amylin Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2011
Acura Pharmaceuticals, Inc. Announces Appointment of Robert Jones as Interim President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSAT Delivery System
Devices Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 11 Apr 2011
Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2011
NewCardio Study Shows my3KG Improves Diagnostic Accuracy in Diabetics With Acute Myocardial Infarction
Devices Diagnostics Cardiology Endocrinology
 HSMN NewsFeed - 7 Apr 2011
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 6 Apr 2011
Spectranetics Announces Approval of LLD in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 1 Apr 2011
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 8 Mar 2011
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2011
Sparton Corporation Completes Acquisition of Byers Peak for $4.35 Million; Jake Rost Appointed as Vice President and General Manager of Sparton Medical Systems
Devices Mergers & Acquisitions Personnel
 HSMN NewsFeed - 15 Feb 2011
ArthroCare Receives FDA Clearance for Spartan 5.5 Needled Suture Implant
Devices Orthopaedic FDA
 HSMN NewsFeed - 9 Feb 2011
Natus Medical Appoints John T. Buhler as President and COO
Devices Personnel
 HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 12 Jan 2011
RaySearch Laboratories: RaySearch Establishes North American Sales Organization
Devices Radiology Personnel
 HSMN NewsFeed - 5 Jan 2011
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
Devices Neurosurgery Orthopaedic Regulatory
 HSMN NewsFeed - 5 Jan 2011
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2010
CE Mark Announced for ArthroCare’s WoundWand(TM) Debridement Device
Devices Wound Care Regulatory
 HSMN NewsFeed - 8 Dec 2010
Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2010
Delcath Submits CE Mark Technical File for Hepatic ChemoSAT Delivery System
Devices Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 2 Dec 2010
Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Nov 2010
Spencer Pharmaceutical to Provide Material Information on the Unsolicited All-Cash Buyout Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2010
Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV (acetaminophen) injection for the Management of Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Nov 2010
ArthroCare Receives FDA Clearance for SpeedFix
Devices Orthopaedic FDA
 HSMN NewsFeed - 28 Oct 2010
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
Devices Surgery Orthopaedic
 HSMN NewsFeed - 18 Oct 2010
Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery
Devices Surgery
 HSMN NewsFeed - 15 Oct 2010
CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall
Devices Product Recall
 HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Oct 2010
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
Devices Cardiology Personnel
 HSMN NewsFeed - 28 Sep 2010
ArthroCare Introduces Complete Ambient ArthroWand Collection
Devices Orthopaedic
 HSMN NewsFeed - 24 Sep 2010
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 13 Sep 2010
U-Systems Receives Approval for Ultrasound Breast Cancer Screening
Devices Regulatory
 HSMN NewsFeed - 18 Aug 2010
T-Ray Science, Inc. Announces Reorganization
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 17 Aug 2010
BioMarin Acquires ZyStor Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2010
FDA Grants Approval of ella(R) for Emergency Contraception
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Aug 2010
Small Bone Innovations, Inc. Announces First RE-MOTION Total Wrist Surgery in Malaysia Through Its Asia-Pacific Joint Venture
Devices Orthopaedic
 HSMN NewsFeed - 11 Aug 2010
TomTec Introduces A New Version of Its 2D CPA Software, an Open Solution for Strain and Time to Peak Velocity Analysis Based on Speckle Tracking
Devices Radiology Cardiology
 HSMN NewsFeed - 10 Aug 2010
TetraLogic Pharmaceuticals Completes $32 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Aug 2010
Toward the Future of Radiation Therapy: MD Anderson's Proton Therapy Center Pioneers Pencil Beam Technology for Cancer Patient Care
Devices Oncology
 HSMN NewsFeed - 2 Aug 2010
Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2010
Cytori's PureGraft System Receives European Approval for Fat Grafting Procedures
Devices Regulatory
 HSMN NewsFeed - 20 Jul 2010
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
Devices Cardiology Reimbursement
 HSMN NewsFeed - 7 Jul 2010
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
Devices FDA
 HSMN NewsFeed - 1 Jul 2010
Bacterin International Appoints Three New Members to Its Board of Directors
Devices Orthopaedic Personnel
 HSMN NewsFeed - 1 Jul 2010
FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2010
Kensey Nash Announces New Collagen Supply Agreement With St. Jude Medical
Devices Interventional
 HSMN NewsFeed - 23 Jun 2010
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2010
David Nichols Joins Knee Creations, LLC. as Senior VP of Product Development & Operations
Devices Orthopaedic Personnel
 HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2010
Spectranetics Plans Randomized Clinical Trial for In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 3 Jun 2010
Javelin Commences Litigation against Hospira and Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreement and Specific Performance Provision Compels Completion of Merger
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 May 2010
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
Personalized Medicine Diagnostics Personnel
 HSMN NewsFeed - 6 May 2010
Medtronic Announces Clinical Trial for Breakthrough Technology in Neurostimulation Therapy for Intractable Chronic Pain
Devices Neurology
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2010
PharmAthene Appoints Eric I. Richman as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2010
Sagent Pharmaceuticals Announces FDA Approval of Mesna Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Apr 2010
Sagent Pharmaceuticals Announces FDA Approval of Granisetron Hydrochloride Injection, USP
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 13 Apr 2010
TomoTherapy Installs 300th Hi-Art(R) Treatment System Worldwide
Devices Oncology
 HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 30 Mar 2010
Ethicon Endo-Surgery Announces Receipt of Offer to Purchase Breast Care Business
Devices Acquisitions
 HSMN NewsFeed - 30 Mar 2010
CryoLife Files for Preliminary Injunction Against Medafor
Devices Distribution Litigation
 HSMN NewsFeed - 19 Mar 2010
CryoLife Comments on Status of Medafor Distribution Agreement
Devices Surgery Distribution
 HSMN NewsFeed - 16 Mar 2010
Organovo Names Marie Csete Executive Vice President of Research and Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 5 Mar 2010
SurModics Announces Organizational and Leadership Changes
Devices Personnel
 HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 16 Feb 2010
Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2010
AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Feb 2010
Boston Scientific Announces Management Changes and Restructuring Initiatives
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Feb 2010
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 5 Feb 2010
Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2010
Cardiac Science Notifies AED Customers of Voluntary Medical Device Recall
Devices Product Recall
 HSMN NewsFeed - 28 Jan 2010
Aubrey Inc. Receives FDA Clearance for AWBAT Plus
Devices Wound Care FDA
 HSMN NewsFeed - 26 Jan 2010
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2010
Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lymphocytic Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Jan 2010
Ethicon Completes Acquisition of Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2010
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2010
ArthroCare Names Scott Schaffner Senior Vice President and General Manager of Sports Medicine
Devices Personnel
 HSMN NewsFeed - 31 Dec 2009
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Dec 2009
David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
Personalized Medicine Personnel
 HSMN NewsFeed - 17 Dec 2009
Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Dec 2009
William D. Young to Become Chairman of Biogen Idec
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2009
Oxford BioTherapeutics Appoints Michael Moore as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2009
NormOxys Appoints Industry Veteran and Recognized Neuroscience Expert, Martin Tolar, MD, PhD, as Company's CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2009
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
Devices Cardiology FDA
 HSMN NewsFeed - 30 Nov 2009
Toshiba Showcases Aquilion ONE's Pediatric Imaging Capabilities
Devices Radiology
 HSMN NewsFeed - 27 Nov 2009
Philips Helps Hospitals Strike Balance Between Innovation and Value
Devices Radiology
 HSMN NewsFeed - 23 Nov 2009
Susan G. Komen for the Cure Founder, Nancy G. Brinker, Calls New Mammography Guidelines a "Setback;" Makes Call to Action
Devices Radiology Oncology
 HSMN NewsFeed - 27 Oct 2009
Lumenis Receives 510(k) Clearance for the PolyScope Disposable Flexible Endoscope
Devices FDA
 HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 408

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 408 additional stories matching:
FulFil
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!